Could Teriparatide Replace Percutaneous Vertebral Augmentation for Patients with Osteoporotic Vertebral Compression Fracture to Some Extent? [Letter]

Abstract

Jiaming Zhou, Yuan Xue Department of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, People’s Republic of ChinaCorrespondence: Yuan XueDepartment of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, People’s Republic of ChinaTel [phone]Fax [phone]Email [email protected] We read with great interest the article by Kong et al.1 In their study, the authors found that for patients with osteoporotic vertebral compression fracture (OVCF), treatment with percutaneous kyphoplasty (PKP) and teriparatide showed a lower risk of new vertebral compression fracture (NVCF) and better clinical outcomes than with PKP and basic treatment (calcium and vitamin D). We wish to express our opinion on this topic. View the original paper by Kong and colleagues  

Keywords

• none